This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Health product recall

pms-REPAGLINIDE (2017-04-04)

Starting date:
April 4, 2017
Posting date:
April 19, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-63042

Affected Products

A. pms-REPAGLINIDE 0.5 mg
B. pms-REPAGLINIDE 1 mg

Reason

Out of specification for degradation product during stability testing in affected lot.

Depth of distribution

Retailers across Canada

Affected products

A. pms-REPAGLINIDE 0.5 mg

DIN, NPN, DIN-HIM
DIN 02354926
Dosage form

Tablet

Strength

0.5 mg

Lot or serial number
  • 1504536
  • 1600499
Companies
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA

B. pms-REPAGLINIDE 1 mg

DIN, NPN, DIN-HIM
DIN 02354934
Dosage form

Tablet

Strength

1 mg

Lot or serial number
  • 1601071
Companies
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA